CASI Pharmaceuticals, Inc. (CASIF): SCHEDULE 13D/A filed May 18, 2026

Form type

SCHEDULE 13D/A

Filing date

May 18, 2026

Accession number

0001104659-26-063233

Filer

CASI Pharmaceuticals, Inc. (CIK 1962738)